PRESS RELEASES

Julie Gralow, MD, FACP, FASCO Appointed Chief Medical Officer of the American Society of Clinical Oncology

(March 2021) Bridge Partners is pleased to announce the appointment of Dr. Julie Gralow as Chief Medical Officer of The American Society of Clinical Oncology.

The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization for physicians and oncology professionals caring for people with cancer. Founded in 1964 with a mission of conquering cancer through research, education, and promotion of the highest quality and equitable patient care. ASCO’s vision is a world where cancer is prevented or cured, and every survivor is healthy.

Dr. Gralow, formerly Professor of Medical Oncology and Director of Breast Medical Oncology at the University of Washington, Fred Hutchinson Cancer Research Center, and the Seattle Cancer Care Alliance, has been named Chief Medical Officer (CMO) of the American Society of Clinical Oncology. She succeeds Dr. Richard Schilsky, who retired in February 2021 after having served as ASCO’s CMO since 2013.

The CMO position provides medical and scientific leadership for ASCO’s research, public policy initiatives, communications efforts, and global programs and services that promote high-quality cancer care, as well as fundraising for ASCO’s affiliated foundation, Conquer Cancer. The CMO is a member of the Executive Leadership Team and reports to the CEO.